PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+8.81%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$5.39B
AUM Growth
+$5.39B
(+16%)
Cap. Flow
+$275M
Cap. Flow
% of AUM
5.1%
Top 10 Holdings %
Top 10 Hldgs %
27.32%
Holding
124
New
25
Increased
32
Reduced
36
Closed
12
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$106M |
| 2 |
Centene
CNC
|
$80.2M |
| 3 |
Spotify
SPOT
|
$58.3M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$52.2M |
| 5 |
Esperion Therapeutics
ESPR
|
$52.1M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$198M |
| 2 |
Microsoft
MSFT
|
$103M |
| 3 |
Baxter International
BAX
|
$88.8M |
| 4 |
Molina Healthcare
MOH
|
$73.3M |
| 5 |
UnitedHealth
UNH
|
$51.2M |
Sector Composition
| 1 | Healthcare | 57.72% |
| 2 | Technology | 11.08% |
| 3 | Communication Services | 8.55% |
| 4 | Consumer Discretionary | 3.05% |
| 5 | Financials | 2.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Jazz Pharmaceuticals
JAZZ
$7.75B
| $213M | 3.34% | 1,238,906 +103,379 | +9% | +$17.8M |
|
|
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $192M | 3% | 5,079,770 -246,901 | -5% | -$9.33M |
|
|
AERI
3
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $184M | 2.88% | 2,720,218 -112,785 | -4% | -$7.62M |
|
4
Elevance Health
ELV
$71.8B
| $168M | 2.64% | 707,244 +46,374 | +7% | +$11M |
|
5
Viatris
VTRS
$12.3B
| $162M | 2.54% | 4,480,720 -143,359 | -3% | -$5.18M |
|
6
Tenet Healthcare
THC
$16.3B
| $146M | 2.28% | 4,336,946 +786,785 | +22% | +$26.4M |
|
|
CLVS
7
DELISTED
Clovis Oncology, Inc.
CLVS
| $106M | 1.66% | +2,337,225 | New | +$106M |
|
8
Alphabet (Google) Class A
GOOGL
$2.57T
| $101M | 1.59% | 89,774 +37,574 | +72% | +$42.4M |
|
9
Zimmer Biomet
ZBH
$21B
| $99.7M | 1.56% | 894,616 +3,195 | +0.4% | +$356K |
|
10
Pacira BioSciences
PCRX
$1.2B
| $99.7M | 1.56% | 3,110,213 +1,405,605 | +82% | +$45M |
|
11
Salesforce
CRM
$245B
| $98.8M | 1.55% | 724,231 +168,423 | +30% | +$23M |
|
|
12
Esperion Therapeutics
ESPR
$448M
| $96.4M | 1.51% | 2,460,157 +1,330,159 | +118% | +$52.1M |
|
13
Puma Biotechnology
PBYI
$254M
| $94.5M | 1.48% | 1,596,783 -435,836 | -21% | -$25.8M |
|
14
Humana
HUM
$36.5B
| $92M | 1.44% | 309,101 -11,349 | -4% | -$3.38M |
|
|
MYOK
15
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $90.3M | 1.41% | 1,819,315 +869,404 | +92% | +$43.2M |
|
16
DaVita
DVA
$9.85B
| $89.2M | 1.4% | 1,285,000 +659,997 | +106% | +$45.8M |
|
17
Baidu
BIDU
$32.8B
| $89.2M | 1.4% | 367,146 +138,324 | +60% | +$33.6M |
|
18
Revvity
RVTY
$10.5B
| $85.1M | 1.33% | 1,161,817 +80,310 | +7% | +$5.88M |
|
19
Abbott
ABT
$231B
| $81.6M | 1.28% | 1,337,288 -419,508 | -24% | -$25.6M |
|
|
20
Centene
CNC
$14.3B
| $80.2M | 1.26% | +651,218 | New | +$80.2M |
|
21
Penumbra
PEN
$10.6B
| $79.4M | 1.24% | 574,400 -72,586 | -11% | -$10M |
|
|
MDCO
22
DELISTED
Medicines Co
MDCO
| $76.7M | 1.2% | 2,088,997 -114,334 | -5% | -$4.2M |
|
23
Hologic
HOLX
$14.9B
| $75.2M | 1.18% | 1,892,703 +319,846 | +20% | +$12.7M |
|
24
Merit Medical Systems
MMSI
$5.36B
| $74.5M | 1.17% | 1,455,616 +598,822 | +70% | +$30.7M |
|
|
25
UnitedHealth
UNH
$281B
| $74.3M | 1.16% | 302,688 -208,583 | -41% | -$51.2M |
|